Severe sinus bradycardia associated with remdesivir in a child with severe SARS-COV-2 infection-reply.
作者信息
Mendez-Echevarria Ana, Sándor-Bajusz Kinga-Amalia, Calvo Cristina
机构信息
Pediatric Infectious and Tropical Diseases Department, Hospital La Paz-IdiPAZ, Traslational Research Network in Pediatric Infectious Diseases (RITIP), Paseo de la Castellana 261, 28046, Madrid, Spain.
Department of Pediatrics, University of Pécs Medical School, Pécs, Hungary.
出版信息
Eur J Pediatr. 2021 May;180(5):1629-1630. doi: 10.1007/s00431-021-03952-0. Epub 2021 Jan 19.
Abstract
摘要
相似文献
1
Severe sinus bradycardia associated with remdesivir in a child with severe SARS-COV-2 infection-reply.一名患有严重SARS-CoV-2感染的儿童使用瑞德西韦后出现严重窦性心动过缓——回复
Eur J Pediatr. 2021 May;180(5):1629-1630. doi: 10.1007/s00431-021-03952-0. Epub 2021 Jan 19.
2
Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection.一名患有严重新型冠状病毒 2 型（SARS-CoV-2）感染的儿童使用瑞德西韦后出现严重窦性心动过缓。
Eur J Pediatr. 2021 May;180(5):1627. doi: 10.1007/s00431-021-03940-4. Epub 2021 Jan 23.
3
Remdesivir, Sinus Bradycardia and Therapeutic Drug Monitoring in Children With Severe COVID-19.瑞德西韦、窦性心动过缓与重症新型冠状病毒肺炎儿童的治疗药物监测
Pediatr Infect Dis J. 2021 Dec 1;40(12):e528-e529. doi: 10.1097/INF.0000000000003309.
4
Sinus Bradycardia in Children Treated With Remdesivir for COVID-19.使用瑞德西韦治疗新冠病毒病的儿童出现窦性心动过缓
Pediatr Infect Dis J. 2021 Sep 1;40(9):e356. doi: 10.1097/INF.0000000000003214.
5
Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.瑞德西韦治疗儿童急性 2019 冠状病毒病合并窦性心动过缓：病例报告及文献复习。
J Pediatric Infect Dis Soc. 2021 Oct 27;10(9):926-929. doi: 10.1093/jpids/piab029.
6
Remdesivir therapy associated with Bradycardia in SARS-CoV2.瑞德西韦治疗与新型冠状病毒肺炎患者心动过缓有关。
Clin Cardiol. 2021 Sep;44(9):1190-1191. doi: 10.1002/clc.23700. Epub 2021 Jul 28.
7
Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).瑞德西韦治疗2019冠状病毒病（COVID-19）患者与短暂性心动过缓
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.025. Epub 2021 May 28.
8
Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.瑞德西韦可能会使2019冠状病毒病患者的心电图出现除心动过缓之外的变化——一项初步研究。
J Med Virol. 2021 Oct;93(10):5724-5725. doi: 10.1002/jmv.27177. Epub 2021 Jul 14.
9
Remdesivir-associated bradycardia.瑞德西韦相关心动过缓。
BMJ Case Rep. 2021 Sep 3;14(9):e245289. doi: 10.1136/bcr-2021-245289.
10
Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者中与瑞德西韦相关的潜在短暂性心动过缓
J Med Virol. 2021 May;93(5):2631-2634. doi: 10.1002/jmv.26898. Epub 2021 Mar 3.
引用本文的文献
1
Therapeutic Strategies for COVID-19 Lung Disease in Children.儿童新冠病毒肺炎的治疗策略
Front Pediatr. 2022 Mar 7;10:829521. doi: 10.3389/fped.2022.829521. eCollection 2022.
2
Remdesivir: Quo vadis?瑞德西韦：路在何方？
Biochem Pharmacol. 2021 Nov;193:114800. doi: 10.1016/j.bcp.2021.114800. Epub 2021 Oct 19.
本文引用的文献
1
COVID-19 and congenital heart disease: a case series of nine children.COVID-19 与先天性心脏病：9 例患儿的病例系列。
World J Pediatr. 2021 Feb;17(1):71-78. doi: 10.1007/s12519-020-00397-7. Epub 2021 Jan 2.
2
Cardiovascular impact of COVID-19 with a focus on children: A systematic review.新冠病毒病对心血管系统的影响（聚焦于儿童）：一项系统综述
World J Clin Cases. 2020 Nov 6;8(21):5250-5283. doi: 10.12998/wjcc.v8.i21.5250.
3
Compassionate use of remdesivir in children with COVID-19.瑞德西韦在 COVID-19 患儿中的同情使用。
Eur J Pediatr. 2021 Apr;180(4):1317-1322. doi: 10.1007/s00431-020-03876-1. Epub 2020 Nov 16.
4
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.瑞德西韦对比标准治疗对 11 天内中症 COVID-19 患者临床状态的影响：一项随机临床试验。
JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.
5
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
6
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
Zotero 插件